DermTech
360Dx Top 30 Rebounds in July After June Swoon
Of the 30 diagnostic companies in the index, 26 saw their share prices increase, while four firms saw stock prices decline.
DermTech Posts 48 Percent Jump in Q1 Revenues
Despite the revenue increase, the La Jolla, California-based skin cancer diagnostics firm missed Wall Street's revenue and earnings expectations.
360Dx Top 30 Drops 11 Percent in April, Following Broader Market Trends
Of the 30 diagnostic companies in the index, every firm's share price dropped by at least 1 percent.
360Dx Top 30 Falls Slightly in March
Of the 30 companies in the index, 17 saw declines in their stock prices, while 13 saw share price increases.
DermTech Q4 Revenues Jump 52 Percent, Miss Wall Street Estimate
The company's revenue gains were driven by higher sales of its noninvasive skin cancer tests.
Nov 9, 2021
Dermtech Q3 Revenues Rise 122 Percent
Aug 5, 2021
DermTech Revenues Nearly Quadruple in Q2
May 14, 2021
DermTech Q1 Revenues up 62 Percent
Mar 5, 2021